相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Molecular Chaperones as Rational Drug Targets for Parkinsons Disease Therapeutics
S. K. Kalia et al.
CNS & Neurological Disorders-Drug Targets (2012)
Transduced Tat-DJ-1 protein protects against oxidative stress-induced SH-SY5Y cell death and Parkinson disease in a mouse model
Hoon Jae Jeong et al.
MOLECULES AND CELLS (2012)
HSP90 Inhibition Is Effective in Breast Cancer: A Phase II Trial of Tanespimycin (17-AAG) Plus Trastuzumab in Patients with HER2-Positive Metastatic Breast Cancer Progressing on Trastuzumab
Shanu Modi et al.
CLINICAL CANCER RESEARCH (2011)
Role for NAD(P)H:quinone Oxidoreductase 1 and Manganese-Dependent Superoxide Dismutase in 17-(Allylamino)-17-demethoxygeldanamycin-Induced Heat Shock Protein 90 Inhibition in Pancreatic Cancer Cells
David Siegel et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2011)
A Mechanistic and Structural Analysis of the Inhibition of the 90-kDa Heat Shock Protein by the Benzoquinone and Hydroquinone Ansamycins
Philip Reigan et al.
MOLECULAR PHARMACOLOGY (2011)
Protective Role of Heat Shock Proteins in Parkinson's Disease
Paolo Aridon et al.
NEURODEGENERATIVE DISEASES (2011)
Potassium carbonate-silica: a highly effective stationary phase for the chromatographic removal of organotin impurities
David C. Harrowven et al.
CHEMICAL COMMUNICATIONS (2010)
Application of Chemoproteomics to Drug Discovery: Identification of a Clinical Candidate Targeting Hsp90
Patrick Fadden et al.
CHEMISTRY & BIOLOGY (2010)
Discovery and development of Hsp90 inhibitors: a promising pathway for cancer therapy
James R. Porter et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2010)
Heat Shock Proteins: Therapeutic Drug Targets for Chronic Neurodegeneration?
M. U. Sajjad et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2010)
ATPase inhibitors of heat-shock protein 90 second season
Yves L. Janin
DRUG DISCOVERY TODAY (2010)
Heat Shock Protein 90: Inhibitors in Clinical Trials
Marco A. Biamonte et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
ATPases as Drug Targets: Insights from Heat Shock Proteins 70 and 90
Andrew J. Massey
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Targeting the dynamic HSP90 complex in cancer
Jane Trepel et al.
NATURE REVIEWS CANCER (2010)
Heat shock proteins in neurodegenerative diseases: Pathogenic roles and therapeutic implications
Hiroaki Adachi et al.
INTERNATIONAL JOURNAL OF HYPERTHERMIA (2009)
Design and synthesis of ansamycin antibiotics
Iwona E. Wrona et al.
COMPTES RENDUS CHIMIE (2008)
Enzymatic reduction and glutathione conjugation of benzoquinone ansamycin heat shock protein 90 inhibitors: Relevance for toxicity and mechanism of action
Wenchang Guo et al.
DRUG METABOLISM AND DISPOSITION (2008)
Mechanistic studies on Hsp90 inhibition by ansamycin derivatives
S. C. Onuoha et al.
JOURNAL OF MOLECULAR BIOLOGY (2007)
Geldanamycin derivatives and neuroprotective effect on cultured P19-derived neurons
Sarin Tadtong et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
Relationship among ligand conformations in solution, in the solid state, and at the Hsp90 binding site: Geldanamycin and radicicol
Pahk Thepchatri et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2007)
Biotransformation of geldanamycin and 17-allylamino-17-demethoxygeldanamycin by human liver microsomes: Reductive versus oxidative metabolism and implications
Wensheng Lang et al.
DRUG METABOLISM AND DISPOSITION (2007)
The bioreduction of a series of benzoquinone ansamycins by NAD(P)H: quinone oxidoreductase 1 to more potent heat shock protein 90 inhibitors, the hydroquinone ansamycins
Wenchang Guo et al.
MOLECULAR PHARMACOLOGY (2006)
Modulation of Hsp90 function in neurodegenerative disorders: a molecular-targeted therapy against disease-causing protein
Masahiro Waza et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2006)
Reaction of geldanamycin and C17-substituted analogues with glutathione: Product identifications and pharmacological implications
RL Cysyk et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2006)
Inhibitors of the HSP90 molecular chaperone: Attacking the master regulator in cancer
Edward McDonald et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2006)
Geldanamycin induces heat shock protein 70 and protects against MPTP-induced dopaminergic neurotoxicity in mice
HY Shen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Heat shock protein 90 inhibitors. A text book example of medicinal chemistry?
YL Janin
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Formation of 17-allylamino-demethoxygeldanamycin (17-AAG) hydroquinone by NAD(P)H:quinone oxidoreductase 1:: Role of 17-AAG hydroquinone in heat shock protein 90 inhibition.
WC Guo et al.
CANCER RESEARCH (2005)
17-AAG, an Hsp90 inhibitor, ameliorates polyglutamine-mediated motor neuron degeneration
M Waza et al.
NATURE MEDICINE (2005)
α-Synuclein phosphorylation enhances eosinophilic cytoplasmic inclusion formation in SH-SY5Y cells
WW Smith et al.
JOURNAL OF NEUROSCIENCE (2005)
Quantum chemical calculations and mutational analysis suggest heat shock protein 90 catalyzes trans-cis isomerization of geldanamycin
YS Lee et al.
CHEMISTRY & BIOLOGY (2004)
NMR chemical shift perturbation study of the N-terminal domain of Hsp90 upon binding of ADR AMP-PNP, geldanamycin, and radicicol
A Dehner et al.
CHEMBIOCHEM (2003)
Crystal structure and molecular modeling of 17-DMAG in complex with human Hsp90
JM Jez et al.
CHEMISTRY & BIOLOGY (2003)
分享论文
